![Enrique Samper Rodriguez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Enrique Samper Rodriguez
Chief Executive Officer at NIMGenetics Genómica y Medicina SL
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Javier Suela Rubio | M | - |
NIMGenetics Genómica y Medicina SL
![]() NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | 16 years |
Sara Alvarez de Andres | M | - |
NIMGenetics Genómica y Medicina SL
![]() NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | 16 years |
Goranka Tanackovic | M | - |
GENE PREDICTIS SA
![]() GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | 13 years |
David de Martin | M | - |
GENE PREDICTIS SA
![]() GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | 3 years |
Anne-Laure Meynier | F | 39 |
GENE PREDICTIS SA
![]() GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | - |
Patrick Chalançon | M | - |
GENE PREDICTIS SA
![]() GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jose Luis Vallejo Pizarro | M | - |
NIMGenetics Genómica y Medicina SL
![]() NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | 10 years |
Juan Cruz Cigudosa | M | - |
NIMGenetics Genómica y Medicina SL
![]() NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | - |
Statistics
Country | Connections | % of total |
---|---|---|
Spain | 4 | 50.00% |
Switzerland | 4 | 50.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Enrique Samper Rodriguez
- Personal Network